- Home
- OSUR vs DBI Comparison
OSUR vs DBI Comparison
Compare OSUR & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- DBI
- Stock Information
- Founded
- OSUR 2000
- DBI 1991
- Country
- OSUR United States
- DBI United States
- Employees
- OSUR N/A
- DBI N/A
- Industry
- OSUR Medical/Dental Instruments
- DBI Clothing/Shoe/Accessory Stores
- Sector
- OSUR Health Care
- DBI Consumer Discretionary
- Exchange
- OSUR Nasdaq
- DBI Nasdaq
- Market Cap
- OSUR 248.3M
- DBI 222.4M
- IPO Year
- OSUR 1986
- DBI 1991
- Fundamental
- Price
- OSUR $3.37
- DBI $3.90
- Analyst Decision
- OSUR Hold
- DBI Hold
- Analyst Count
- OSUR 2
- DBI 2
- Target Price
- OSUR $5.50
- DBI $4.75
- AVG Volume (30 Days)
- OSUR 699.3K
- DBI 1.7M
- Earning Date
- OSUR 05-07-2025
- DBI 03-20-2025
- Dividend Yield
- OSUR N/A
- DBI 5.16%
- EPS Growth
- OSUR N/A
- DBI N/A
- EPS
- OSUR N/A
- DBI N/A
- Revenue
- OSUR $185,827,000.00
- DBI $3,009,262,000.00
- Revenue This Year
- OSUR N/A
- DBI $3.51
- Revenue Next Year
- OSUR $7.46
- DBI $2.60
- P/E Ratio
- OSUR N/A
- DBI N/A
- Revenue Growth
- OSUR N/A
- DBI N/A
- 52 Week Low
- OSUR $2.69
- DBI $3.20
- 52 Week High
- OSUR $6.35
- DBI $11.06
- Technical
- Relative Strength Index (RSI)
- OSUR 45.10
- DBI 47.44
- Support Level
- OSUR $3.34
- DBI $3.71
- Resistance Level
- OSUR $3.56
- DBI $4.42
- Average True Range (ATR)
- OSUR 0.15
- DBI 0.31
- MACD
- OSUR -0.00
- DBI 0.05
- Stochastic Oscillator
- OSUR 10.53
- DBI 48.00
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.